Broad Institute to Use Fluidigm Access Array for Targeted Resequencing | GenomeWeb

This article was originally published on May 25.

Fluidigm said today that the Broad Institute has purchased an Access Array system to automate sample prep for targeted resequencing.

Access Array enhances the capabilities of next-generation sequencing platforms by allowing the preparation of several sample libraries in parallel, Fluidigm said. The multiplexed system enables parallel amplification of 48 samples — the equivalent of 48 sequencing libraries — in a few hours, according to the company.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.

Mar
02
Sponsored by
VelaDx

This online seminar will highlight recent advances in the use of next-generation sequencing to detect drug-resistant mutations in patients with HIV or HCV.